Skip to content

OculoMax: what changed

BE 0805.811.563NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€216,933
2024 · €148,773+€68,160
Equity
€393,054
2024 · €176,120+€216,933
Cash
€386,227
2024 · €86,109+€300,119
Balance sheet total
€466,509
2024 · €220,752+€245,757

Largest movements

2024 to 2025
Assets
  • Cash +€300,119

    up €300,119 (+349%), from €86,109 to €386,227

    mainly Net result for the year (+€216,933) and Current investments (+€69,000)

  • Receivables within one year +€76,140

    new in 2025: €76,140

  • Current investments -€69,000

    no longer reported in 2025 (was €69,000)

  • Deferred charges and accrued income -€61,501

    down €61,501 (-93.7%), from €65,643 to €4,142

Equity and liabilities
  • Reserves +€216,933

    up €216,933 (+125%), from €174,120 to €391,054

  • Tax, wage and social debts +€22,044

    up €22,044 (+49.6%), from €44,456 to €66,500

    of which Taxes: +€22,500

  • Other debts +€6,612

    up €6,612, from €0 to €6,612

Income statement
  • Gross operating margin +€87,983

    up €87,983 (+45.4%), from €193,828 to €281,811

  • Taxes +€22,954

    up €22,954 (+52.4%), from €43,816 to €66,770

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €148,773
Gross operating margin +€87,983
Depreciation +€1,013
Other operating charges -€20
Financial income +€2,141
Financial charges -€2
Taxes -€22,954
Result 2025 €216,933
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€231,119
Investment +€69,000
Financing €0
Cash 2024 €86,109
Net result for the year +€216,933
Receivables within one year -€76,140
Deferred charges and accrued income +€61,501
Trade debts +€168
Tax, wage and social debts +€22,044
Other debts +€6,612
Current investments +€69,000
Cash 2025 €386,227
brings cash intakes cash out
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €220,752 €466,509 +€245,757 +111%
Formation expenses 20 €0 €0 =
Current assets 29/58 €220,752 €466,509 +€245,757 +111%
Amounts receivable within one year 40/41 - €76,140 +€76,140
Trade receivables 40 - €76,140 +€76,140
Current investments 50/53 €69,000 - -€69,000
Cash at bank and in hand 54/58 €86,109 €386,227 +€300,119 +349%
Deferred charges and accrued income 490/1 €65,643 €4,142 -€61,501 -93.7%
Total equity and liabilities 10/49 €220,752 €466,509 +€245,757 +111%
Equity 10/15 €176,120 €393,054 +€216,933 +123%
Contributions 10/11 €2,000 €2,000 = 0.0%
Reserves 13 €174,120 €391,054 +€216,933 +125%
Distributable reserves 133 €174,120 €391,054 +€216,933 +125%
Amounts payable 17/49 €44,632 €73,455 +€28,824 +64.6%
Amounts payable within one year 42/48 €44,632 €73,455 +€28,824 +64.6%
Trade debts 44 €176 €344 +€168 +95.6%
Suppliers 440/4 €176 €344 +€168 +95.6%
Taxes, remuneration and social security 45 €44,456 €66,500 +€22,044 +49.6%
Taxes 450/3 €44,000 €66,500 +€22,500 +51.1%
Remuneration and social security 454/9 €456 - -€456
Other amounts payable 47/48 €0 €6,612 +€6,612
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,013 - -€1,013
Other operating charges 640/8 €182 €202 +€20 +10.9%
Gross operating margin 9900 €193,828 €281,811 +€87,983 +45.4%
Operating profit (loss) 9901 €192,634 €281,609 +€88,975 +46.2%
Financial income 75/76B - €2,141 +€2,141
Recurring financial income 75 - €2,141 +€2,141
Non-recurring financial income 76B - €2,141 +€2,141
Financial charges 65/66B €45 €47 +€2 +3.5%
Recurring financial charges 65 €45 €47 +€2 +3.5%
Profit (loss) for the period before taxes 9903 €192,589 €283,703 +€91,114 +47.3%
Income taxes 67/77 €43,816 €66,770 +€22,954 +52.4%
Profit (loss) for the period 9904 €148,773 €216,933 +€68,160 +45.8%
Profit (loss) for the period to be appropriated 9905 €148,773 €216,933 +€68,160 +45.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€659,520 to €844,717

Midpoint €736,685 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €393,054
Capitalised earnings €925,986 to €1.3m
Indication €659,520 to €844,717

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€393,054
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€393,054

Capitalised earnings

net result for the year (9904)
2025
€216,933
excluding non-recurring income and charges
€214,793
2024
€148,773
2023
€25,347
Average result, excluding non-recurring income and charges
€129,638
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€925,986 / €1.1m / €1.3m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 14 November 2026 via checked.be.